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Summary. Detailed characterization of the subdermal
model is a significant tool for better understanding of
calcification mechanisms occurring in heart valves. In
previous ultrastructural investigation on six-week-
implantated aortic valve leaflets, modified pre-
embedding glutaraldehyde-cuprolinic-blue reactions
(GA-CB) enabled sample decalcification with
concurrent retention/staining of lipid-containing
polyanionic material, which lined cells and cell-derived
matrix-vesicle-like bodies (phthalocyanin-positive
layers: PPLs) co-localizing with the earliest apatite
nucleation sites. Additional post-embedding silver
staining (GA-CB-S) revealed PPLs to contain calcium-
binding sites. This investigation concerns valve leaflets
subjected to shorter implantation times to shed light on
the modifications associated with PPLs generation and
calcification onset/progression. Spectrometric
estimations revealed time-dependent calcium increase,
for unreacted samples, and copper modifications
indicating an increase in acidic, non-glycanic material,
for GA-CB-reacted samples. Two-day-implant thin
sections showed emission and subsequent reabsorption
of lamellipodium-like protrusions by cells, originating
ECM-containing vacuoles, and/or degeneration stages
characterized by the appearance of GA-CB-S-reactive,
organule-derived dense bodies and progressive
dissolution of all cell membranes. In one-week-implants,
the first PPL-lined cells were found to co-exist with cells
where GA-CB-S-reactive material accumulated, or
exudated towards their edges, or outcropped at the ECM
milieu, so acquiring PPL features. PPL-derived material
was observed increasingly to affect the ECM on thin
sections of one-week- to six-week-implants. These
results show an endogenous source for PPLs and reveal
that a peculiar cascade of cell degenerative steps is
associated with valve mineralization in the subdermal
model, providing new useful parameters for more
reliable comparison of this experimental calcification
process versus the physiological and pathological
processes.
Key words: Aortic valve calcification, Ultrastructural
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Introduction
Detailed characterization of any animal model is a
significant tool for both biological and clinical purposes
because it provides clues for (i) better understanding of
the mechanisms occurring in various calcification
processes; (ii) more reliable screening of anti-
mineralization properties of existing heart bioprosthetic
valves; and (iii) more appropriate design of novel
bioprostheses.
The subcutaneous implant model is the most widely
used experimental approach for predicting post-
operative susceptibility to calcification of heart
bioprosthetic valves because of their relatively low cost
and the precocity of mineralization onset, which starts
within a few hours, and accelerated mineralization,
which terminates within 8 weeks (Schoen et al., 1985;
Mako and Vesely, 1997). In addition, structural changes
were found to closely mimic those in circulatory models
or in surgical explants (Schoen et al., 1985, 1992). These
findings are consistent with the accepted concept that
calcification generally occurs according to common
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patterns (Fishbein et al., 1982; Anderson, 1983;
Bonucci, 1984; Boskey et al., 1988). However, it has
also been claimed that distinct differences exist among
different types of mineralization, for example dystrophic
versus physiological calcification (Nimni et al., 1988), or
bioprosthetic valve calcification versus native (Chanda
et al., 1997).
Additional insights concerning the involvement of
specific molecules, such as proteoglycans and lipids
(Jorge-Herrero et al., 1991), alkaline phosphatase
(Maranto and Schoen, 1988; Levy et al., 1991),
osteocalcin (Levy et al., 1980, 1983), or osteopontin
(Shen et al., 1997; Srivatsa et al., 1997) in valve
mineralization, support the idea that at least some
features are shared by all calcification types.
Investigations into tissue changes during
calcification onset and progression in subdermally
implanted porcine aortic valve leaflets (Schoen et al.,
1985) and pericardium-derived valve bioprostheses
(Schoen et al., 1986) have supplied additional
information on the mechanisms underlying this
mineralization process: cell plasmalemmas, cell-derived
matrix-vesicle-like bodies, mitochondria and nuclei have
been identified as major apatite crystal nucleators, with
collagen fibrils possibly acting as minor ones.
Further ultrastructural insights have been acquired
into the valve calcification process in heterologous
subdermal environments using modified histochemical
procedures involving sample unmasking from mineral
with associated retention and visualization of
polyanionic lipid material (Ortolani et al., 2002a,b,
2003). Namely, (i) modified pre-embedding reactions
with copper phthalocyanin Cuprolinic Blue (GA-CB)
revealed peculiar electron-dense layers (Phthalocyanin
Positive Layers: PPLs) lining cells and cell-derived
matrix-vesicle-like bodies, co-localising with the earlier
sites of apatite crystal nucleation; (ii) additional post-
embedding von Kossa silver staining (GA-CB-S) applied
to electron microscopy showed PPLs to be rich in
calcium-binding sites; and (iii) modified reactions with
Malachite Green showed PPLs also to contain acidic
phospholipid moieties. In addition, PPL-like material
was observed to spread outside mineralized cells
triggering ECM calcification.
The above results were observed for 6-week-long
subdermal implantations only. It was not possible to
assess all the upstream tissue modifications or to
understand whether PPL formation should be ascribed to
endogenous or exogenous phenomena. In the present
investigation, the above modified histochemical
procedure and spectrometric analyses were extended to
porcine aortic valve leaflets retrieved from rat subcutis
after different implantation times. The aim was to assess
(i) how cell degeneration starts; (ii) how it correlates
with early calcification; (iii) and how PPLs generate.
Spectrometric analyses showed a time-dependent
increase of calcium amounts and peculiar changes in
copper amounts, indicating that actually non-glycanic
polyanion accumulation is associated with calcific
progression in the subdermal model. In addition,
ultrastructural analysis revealed specific time-related
changes including increasing release and clustering
within cells of GA-CB-S-reactive material which proved
to represent an endogenous PPL-source, because of
subsequent layering and outcropping at cell surfaces.
Material and methods
Subcutaneous implant model
Fifteen aortic roots were dissected from adult pigs
(n=15; mean age and weight were 18 weeks and 80 kg,
respectively) and subjected to experimental calcification
(Schoen et al. 1986). The samples were suspended in
0.625% (w/v) glutaraldehyde (Fluka, BioChemika) in
degassed and continuously stirred 10 mM borate buffer,
pH 7.4, containing 0.9% (w/v) NaCl, in the dark and
under N2 atmosphere. After 6 h, the aortic roots were re-
suspended in fresh solution, treated in the same
conditions for a further 16 h, and then stored in 0.2%
(w/v) glutaraldehyde in borate buffer for 2 days. Fifteen
aortic valve leaflets, dissected from the above aortic
roots (1 leaflet per root) and subdermally implanted into
abdominal pouches obtained in 3-week-old male
Sprague-Dawley rats (1 leaflet per rat) for 2 days, 1
week, 2 weeks, 4 weeks or 6 weeks (n=3 for
implantation time). After retrieval, the valve leaflets
were washed for 1 min, once in 0.9% (w/v)NaCl and
twice in deionized water, and then freeze-dried.
Sampling
After rehydration of the valve leaflets with 10mM
borate buffer, pH 7.4, containing 0.9% (w/v) NaCl,
samples were excised and grouped into 3 lots for light
microscopy, electron microscopy and mass spectrometry,
respectively. Control samples were excised from
unimplanted valve leaflets. The samples were sized to
about 8 mm x 2 mm for the first lot, to about 1 mm x
1mm for the second lot, or reduced to 2±0.2 mg in
weight for the third lot.
Light microscopy
Samples from lot 1 plus control samples were
dehydrated in graded ethanols and embedded in paraffin.
Histological sections underwent von Kossa silver
staining and were mounted on glass slides.
Subsequently, the sections underwent incubation in 1%
AgNO3 aqueous solution at room temperature with
exposure to sunlight for 15 min; washing in distilled
water and drying; and reduction with 5% sodium
thiosulphate in aqueous solution for 5 min at room
temperature.
Electron microscopy 
Samples from lot 2 plus control samples were
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processed for both conventional visualization and
histochemical localization of polyanions and Ca-binding
sites.
Conventional processing
Samples underwent fixation with 2.5% glutar-
aldehyde in 0.1M phosphate buffer, pH 7.4; post-
fixation with 2% OsO4 dissolved in buffer as above;dehydration in graded ethanols; and embedding in
Araldite/Epon.
Histochemical processing for polyanion localization (GA-
CB reaction)
Samples were washed in 25 mM sodium acetate
solution containing 0.05M MgCl2, pH 4.8, for 1 h;
fixed/reacted with 2.5% glutaraldehyde (GA) and 0.05%
Cuprolinic Blue (CB) (Electron Microscopy Science) in
acetate buffer as above, overnight, using an Agar
specimen rotator; washed twice in acetate buffer as
above; washed in 0.1M phosphate buffer, pH 7.2; and
post-fixed with 2% OsO4 dissolved in 0.1M phosphatebuffer as above, for 1h. The GA-CB-reacted samples
were then post-fixed and embedded with conventional
procedure as above.
Histochemical processing for the localization of Ca-
binding sites (GA-CB-S reaction)
Semi-thin sections from samples of lot 2 (GA-CB-
reacted sections) were subjected to post-embedding von
Kossa silver staining as for the histological sections,
except for incubation and reduction phase temperature,
which was set at 80°C by placing the glass slides on
warm plates. Ultrathin sections were taken from these
GA-CB-S-reacted semi-thin sections once re-embedded.
Namely, after top cutting, conic Beem capsules (Agar
Scientific) were (i) cut at the top, (ii) placed onto slides
encircling single mounted semi-thin sections, (iii) glued
at their bases, (iv) and filled with epon-araldite fluid.
After resin-polymerization, these new inclusions were
detached from the slides after freezing at -80°C and
subjected to ultramicrotomy.
Staining and recording
All ultrathin sections were placed on formvar-coated
copper grids, Slot 2x1, and contrasted with uranyl
acetate and lead citrate. Observations and micrographic
records were made using a Philips CM12 transmission
electron microscope.
Mass spectrometry
Samples from lot 3 plus control samples were
subjected to GA-CB-reactions (i) at 0.05M MgCl2 CEC
conditions, as for lot 2 samples, and (ii) 0.3M MgCl2CEC conditions. After the GA-CB-reactions, the
samples were solubilized by digestion with 50µL of
concentrated HNO3 (65%), at 50°C for 10 min. The
resulting solutions were diluted to 1 mL with ultrapure
water.
For ICP-MS analyses, all chemicals used were of
analytical reagent-grade quality and were used as
received. Stock standard solutions of both Ca and Cu for
ICP analyses were obtained by diluting as required the
corresponding 1000 mg/L standard solution for ICP
(Merck) with ultrapure water, purified with an Elgastat
UHQ-PS system, in all cases with the addition of 0.5 %
ultrapure-grade 65% HNO3 (Merck Suprapur). All
spectrometric measurements were performed using a
Spectromass 2000 Type MSDIA10B (Spectro Analytical
Instruments, D). The working frequency was 27.12 MHz
with an RF power of 1350 W. Pure argon (transistor
quality) was used for all measurements. Measurements
were performed after calibrating the gas flows and the
plasma position with respect to the interface and the ion-
optical parameters to maximize the signal over
background noise for both analytes investigated.
Optimization was achieved by using the two 1000 mg/L
standard solutions, prepared as described above,
containing calcium and copper, respectively. All
analytical data were collected under standard laboratory
conditions, i.e., not in a clean-room environment.
Calcium isotope 44 and copper isotope 65 were used.
Results were the mean of 10 measurements. 
Results
Spectrometric estimations of Ca content in samples
from explanted valve leaflets revealed that
mineralization had already started in 2-day implants and
increased progressively with time, rising tenfold in 6-
week implants versus 2-day-ones (Fig. 1). In control
samples from unimplanted valve leaflets, only negligible
traces of Ca were detected.
Since histochemical CB-reactions used for
ultrastructural analysis do not provide quantitative
outcomes, and CB is a copper-phthalocyanin,
spectrometric estimations of Cu retained by explants
previously subjected to GA-CB-reaction and washing
were carried out to gain quantitative information on
reaction rates (Fig. 2). As expected, lower quantities of
Cu were detected in unimplanted samples after reactions
performed at 0.3M CEC conditions than at 0.05M. After
reactions at 0.3M CEC conditions, amounts of Cu
retained fell progressively according to implantation
times up to 2 weeks, with an almost 70% decrease,
tending to plateau for the two longer implantation times.
After reactions performed at 0.05M CEC conditions, Cu
content diminished up to 2 weeks as for 0.3M CEC
conditions, but at a slower rate, falling by about 30%
versus 70%. Moreover, a reverse trend was observed for
longer implantation times, with a slight increase of about
7% between 2 and 4-week implantation times, and an
increase of about 15% between 2 and 6 weeks.
After von Kossa staining, histological sections (not
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shown) supported previous reports concerning
subcutaneously implanted aortic valve leaflets (Ferrans
et al., 1980; Levy et al., 1983; Schoen et al., 1985;
Ortolani et al., 2002a), including the appearance of first
mineralization within the intermediate layer, the tunica
spongiosa, as well as more advanced progression of the
process in this layer versus the two surfacing layers, the
tunica ventricularis and tunica fibrosa.
For concision, the following observations will be
restricted to this intermediate layer.
On histological sections (not shown), 2-day-implants
showed diffuse silver precipitation on the body of many
cells and complete unreactivity for the ECM. In 1-week-
implants, the great majority of cells proved to be
reactive, with several being weakly stained at the cores
and markedly stained at the edges. This latter reactivity
pattern became prevalent in sections from 2-week-
implants, where initial silver precipitation also involved
juxtacellular ECM. On sections of 4-week- and 6-week-
implants, increased silver precipitation was observed in
ECM, revealing the presence of increasingly numerous,
broad calcific foci.
After traditional processing (not shown), thin
sections of 2-day-implants revealed initial calcification
consisting of amorphous calcium deposition on most
interstitial cells, with marked masking effects. Some
apatite crystal was occasionally found on cell surfaces or
at mitochondrion level. Increased mineralization in 1-
week-implants was revealed by amorphous calcium
deposition affecting all cells, as well as initial
precipitation of apatite crystals around several cells. On
thin sections of 2-week-implants, prominent
precipitation of apatite crystals was present at the edges
of most cells, also involving juxtacellular ECM. Further
crystal precipitation in ECM was observed on thin
sections of 4-week- and 6-week-implants because of
increasingly numerous, extensive calcific foci.
Owing to concurrent decalcification effect, pre-
embedding CB-reactions clearly revealed a specific
repertoire of cell features on 2-day-implant thin sections.
These observations were (i) the presence of many
convoluted lamellipodium-like cytoplasmic protrusions;
(ii) heterogeneous cytoplasm vacuolization; (iii) the
appearance of seemingly lysosome-derived dense
bodies; (iv) scarcity of ribosomes, and (v) weakening
and/or initial dissolution of plasmalemmas, nuclear
envelopes and organule membranes (Fig. 3A-F).
Cytomembrane dissolution and a concurrent increase in
electron-density of adjacent material led to their
appearance as electron-lucent linear profiles against a
dark background (Fig. 3B,C). The occasional presence
of crista-derived cross striations enabled prompt
identification of degenerating mitochondria among the
organules involved in dense body generation. The largest
heterogeneous vacuoles clearly appeared to result from
secondary self-merging of adjacent cytoplasmic lamellae
(Fig. 3D) or the merging of their free edges with the cell
body (Fig. 3E). These phagosome-like vacuoles
therefore contained ECM-derived particles (Figs. 3C-F).
Confluencing of these large vacuoles and dense bodies
was also often apparent (Fig. 3C-F). More advanced
alteration stages were represented by: (i) cell outlines
acquiring blunt features (Fig. 3F,G) because of complete
re-absorption of lamellipodia; (ii) overall membrane
dissolution; and (iii) increasing cytoplasm electron-
density, spanning the entire cytoplasm (Fig. 3G). The
accumulating osmiophylic, CB-reactive material which
caused the increase in cytoplasm electron-density is here
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Fig. 1. Total amount of Ca estimated after digestion with HNO3 of aortic
valve leaflets subdermally implanted for 2 day- to 6 week-long times.
Fig. 2. Total amount of Cu estimated after digestion with HNO3 of aortic
valve leaflets subdermally implanted for 2 day- to 6 week-long times and
then subjected to GA-CB-reactions at 0.05M and 0.3M CEC conditions.
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Fig. 3. Tunica spongiosa of porcine aortic valve leaflet implanted in rat sub-cutis for 2 days. A, C-E. Presence of lamellipode-like extrusions. A, G.
Presence of dense bodies. B. CB-reactivity associated with organule degeneration: a degenerating mitochondrion is recognizable (arrow). C-G.
Cytoplasm vacuolization and cytomembrane disappearance. G. A Cytoplasm filled with GB-reactive material (PPM) is indicated by a black-and-white
arrow; a black arrow points electronlucent profiles subsequent to plasmalemma dissolution after lamellipodium twining and re-compactation. 
A, x 10,500; B, x 38,000; C, x 10,000; D, E, x 12,000; F, x 19,000; G, x 9,500
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Fig. 4. Tunica spongiosa of porcine aortic valve leaflet implanted in rat sub-cutis for 1 week. A. Co-presence of vacuolated cells (VC) and cells lined by
phthalocyanine-positive-layers (PPL). B. Presence of diffuse PPM within vacuolated cells. C. Moving of PPM towards cortical cytoplasm. A, D, E.
Presence of PPLs. D. Budding of matrix-vesicle-like bodies (MV). E. precocious PPL generation with associated detaching of marginal cytoplasm
fragments (mcf). A, x 12,000; B, x 8,000; C, x 6,000; D, x 17,000; E, x 11,000
referred to as PPM (phthalocyanin-positive material).
On thin sections of CB-reacted 1-week-implants, the
cells exhibited further features suggesting ongoing serial
changes, with the two end-points represented by
vacuolated cells, as for 2-day-implants, and still rare
cells which were lined by 40 to 60 nm-thick electron-
dense layers (Fig. 4A). These pericellular layers were
identical to the phthalocyanin-positive layers already
described for 6-week-implant cells and named PPLs
(Ortolani et al., 2002a), as in the current work.
Transitional features were represented by cells
exhibiting diffuse PPM in cytoplasms (Fig. 4B) and cells
where the original electron-transparency was being
recovered in the inner cytoplasm while electron-density
was increasing in the cortical cytoplasm (Fig. 4C).
Within the cleaned cytoplasms, the (i) absence of
ribosomes; (ii) sporadic presence of membrane-deprived
organule ghosts; and (iii) permanence of the
cytoskeleton network were observed.
Collectively, the stages observed indicated that PPM
was first released filling the whole cytoplasm, and then
moved centrifugally to condensate at cell edges so
forming PPLs, which gave rise to initial blebbing of
cytoplasm-lacking matrix vesicle-like bodies (Fig. 4D).
PPM did not reach the cell surface as a rule, because
premature condensation into PPL was sometimes
occurring within the cortical cytoplasm; subsequent
detachment of marginal cytoplasm fragments in any case
entailed secondary PPL exposure to the ECM (Fig. 4E).
Thin sections of CB-reacted 2-week-implants
showed most cells exhibiting PPLs, which topically
seemed to spread outwards embedding electron-lucent
collagen fibrils (Fig. 5A) and elastin fibers (Fig. 5B).
No further degenerative features were observed on
thin sections of 4-week- and 6-week-implants, the only
apparent difference being an increasingly marked
spreading of CB-reactive material into the ECM.
Post-embedding von Kossa reactions performed on
semi-thin sections of CB-reacted implants entailed
selective deposition of metallic silver, as the derived thin
sections revealed in more detail.
Thin sections from all samples, both implanted and
unimplanted, shared silver precipitation sites (i) within
nuclei, where metal granules scattered throughout the
heterochromatin; and (ii) at the collagen fibril surfaces,
along which punctate metal particles adhered with quasi-
D-periodical patterns. 
Further, distinct silver deposition sites appeared for
implanted valve leaflets. On 2-day- and 1-week-implant
thin sections, additional sites were represented by (i) the
electron-dense material forming both dense bodies and
PPM, and (ii) the ECM-derived intravacuolar particles
(Fig. 6A,C). 
On thin sections of 1-week- to 6-week-implants,
PPLs appeared as the major reactive sites because of the
greater density and size of silver precipitates (Fig.
6B,D). In addition, PPM-lacking cytoplasms became
completely unreactive, except for the nuclear
heterochromatin, whereas reactivity was exhibited by
PPL-associated floccular material lying at their outer
aspect. The same reactivity of PPLs was apparent for
PPL-like material spreading into the ECM embedding
267
Tissue changes in calcific aortic valves
Fig. 5. Tunica spongiosa of porcine aortic valve leaflet implanted in rat sub-cutis for 2 weeks. A. Presence of PPL and initial spreading of PPL-like
material toward the ECM, embedding groups of electronlucent collagen fibrils (double arrows). C: unaffected collagen fibrilis. B. PPL-like material
enveloping an iuxta-cellular elastin fiber (E). A, x 12,000; B, x 20,000
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Fig. 6. Tunica spongiosa of porcine aortic valve leaflet implanted in rat sub-cutis for 2 days (A), 1 week (C), and 2 weeks (B, D-F). A-F. Distribution of
metallic silver granules on thin sections derived from von-Kossa-reacted and re-embedded semithin sections. Silver precipitation exhibited by: (i)
nuclear heterochromatin (A-C); (ii) intravacuolar particles (A); (iii) dense bodies (A); peripheral cytoplasm (A); (iv) PPM (C); (v) PPLs (B, D-F); (vi) and
PPL-like material embedding collagen fibrils and elastin fibers (E) (E,F). A, x 39,000; B, x 36,000; C, x 41,000; D, x 42,000; E, x 24,000; F, x 22,000
collagen fibrils and elastin fibers (Fig. 6E,F).
Discussion
The present data add significant information on the
tissue changes underlying calcification onset and
progression in subdermally implanted aortic valve
leaflets and shed light upon the early cell changes and
subsequent cascade of degenerative steps preceding the
formation of the peculiar mineralization-associated
structures called PPLs, as previously described for 6-
week implants (Ortolani et al., 2002a,b, 2003).
The spectrometric estimations of Ca indicated that
tissue calcification begins within a very short time after
implantation and proceeds with implantation time
according to a grossly linear pattern, consistently with
previous data demonstrating a progressive increase in
mineralization to take place in subdermally implanted
aortic valves, starting 2 days after implantation, reaching
half of the maximum after 3 weeks and the maximum
after 8 weeks (Schoen et al., 1985, 1992; Levy et al.,
1991). Thus the earliest modifications observed in 2-day
implants actually coincided with mineralization onset. 
On the basis of previous results (Ortolani et al.,
2002a,b) and comparing the observed ultrastructural
patterns with the above quantitative results, it appears
that: (i) the majority of the estimated Ca will come from
deposited amorphous calcium salts, for implants up to 1
week; (ii) additional Ca will come from the needle-
shaped apatite crystals accumulating around the cells, for
implants older than one week; and (iii) more and more
Ca will come from apatite crystals formed at the level of
juxtacellular ECM, for implants older than two weeks.
Among the calcium-binding sites ultrastructurally
revealed by thin sections after GA-CB-S reactions, PPLs
and associated proteinaceous material actually
colocalized with the earlier apatite crystal precipitation
sites appearing on thin sections after conventional
processing. 
Since heterogeneous crystallization occurring in
biological environments needs the presence of a suitable
solid surface acting as a nucleator (Boistelle, 1986), this
factor can be represented by the PPL-forming lipidic
material, once it is sufficiently condensed and outcrops
at the ECM milieu.
If PPL can be identified as an ideal substrate for
apatite nucleation, valve stroma can be viewed as an
ideal environment for crystal nucleation progression into
the ECM, taking into account that rapid apatite
proliferation takes place in apatite-enriched serum
(Neuman and Neuman, 1958) and a similar medium is
represented by rat fluids insudating valve stroma.
Consistently, apatite nucleation throughout the ECM will
be enhanced by both the spread of PPL-like material
outside the cells and the scattering of PPL-derived MV-
like bodies, which were also positive to selective
metallic silver precipitation.
The additional silver precipitation observed on
nuclear heterochromatin and along collagen fibrils in
both implants and control samples, seems not to
correlate with mineralization processes, as previously
discussed for 6-week implants (Ortolani et al., 2003).
The rationale in estimating Cu amounts retained in
samples previously subjected to CB-reactions was that
this copper-phthalocyanin binds anionic radicals. This
parameter is therefore an indirect assay of polyanion
content.
The implantation time-dependent changes in Cu
retention were significantly different at 0.3M salt CEC
conditions versus 0.05M. It is well known that 0.3M salt
CEC conditions restrict CB-reactivity to sulphated
glycosaminoglycans, whereas reactivity also includes
non-sulphated glycosaminoglycans, namely hyaluronic
acid, as well as non-glycanic polyanions such as
nucleotides, at 0.05M (Scott and Dorling, 1965; Scott,
1980).
In 2-day and 1-week implants, reactivity decreased
for both CEC conditions, but at a slower rate for 0.05M
versus 0.3M. Taken together, these results indicate that
progressive proteoglycan loss/alteration will occur, as
was previously found (Ortolani et al., 2002b). However,
the slower Cu decreasing for 0.05M CEC conditions
indicates a concurrent increase in polyanionic molecules
other than glycosaminoglycans.
This assumption was strengthened by the results
concerning the implants older than two weeks, since the
amounts of retained Cu tended to plateau for 0.3M CEC
conditions, suggesting that loss/degradation of
sulphated-glycosaminoglycans had stopped, whereas a
trend reversal was apparent for 0.05M CEC conditions,
with a possible slight increase taking place between 2
and 4 weeks, and a significant increase between 4 and 6
weeks. Since it is unlikely that additional acidic material
may include hyaluronic acid, only non-glycanic anionic
substances will be concerned.
Taking into account that GA-CB reactions at 0.05M
CEC conditions revealed the first PPLs in 1-week
implants and became more and more frequent with
implantation times, it is evident that a close relationship
exists between the observed increase in copper-linking
PPLs and the calculated increase in copper-linking, non-
glycanic material, which can actually be regarded as a
major PPL component.
Moreover, an endogenous source of PPLs was
clearly revealed by the appearance of CB-reactive dense
bodies replacing degenerating organules at first, and the
subsequent appearance of an additional CB-reactive
substance which invaded the entire cytoplasm before
moving centrifugally up to stratify into PPLs.
Consistently, both dense bodies and PPM were also
selective sites for earlier metallic silver precipitation, as
observed on thin sections after GA-CB-S reactions. 
The derivation of the initial dense bodies was less
clear. Concurrent disappearance of cytomembranes and
the increase in electron-density of adjacent cytoplasm
enabled the clear identification of degenerating
mitochondria and nuclear envelopes but other dense
bodies resembled remnants of lysosomes or endoplasmic
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reticulum cisternae. It is likely that accumulation of
lysophospholipids may have generated the first dense
bodies, while subsequent, general dissolution of
membrane phospholipidic bilayers was a major co-factor
in the accumulation of lipid-derived products,
contributing to the formation of additional dense bodies
as well as diffuse electron-dense material. 
On the whole, the acidic nature of accumulating
lipidic material will depend on the co-presence of
membrane-derived acidic phospholipids, as
histochemically shown for 6-week implants (Ortolani et
al., 2003), cardiolipin released from inner mitochondrial
membranes, and liberation/accumulation of free fatty
acids. It must be taken into account that hypoxic/anoxic
conditions affect still viable valve cells during pre-
implantation treatments, possibly activating
phospholipase activities (Abe et al., 1987; Nakano et al.,
1990) and/or inducing the accumulation of lactic acid
with subsequent hydrolytic effects, as experimentally
shown (Barrier et al., 2005).
In addition, the observation of frequent fusion
between the above electron-dense inclusions and
intracellular vacuoles containing ECM-derived material,
which also exhibited positivity to silver staining,
suggests that both propensity to calcification and acidity
of this PPL-forming material may be also ascribed to the
co-presence of products resulting from proteoglycan
degradation. In this view, it must be taken into account
that calcific properties were reported for modified
proteoglycans in physiological calcification (Poole et al.,
1982; Arsenault and Ottensmeyer, 1984; Shepard and
Mitchell, 1985; Addadi et al., 1987; Takagi et al., 1989;
Boskey et al., 1997) and for calcific valve bioprostheses
(Jorge-Herrero et al., 1991). 
Interestingly, phthalocyanin Alcian Blue staining of
human aortic valves affected by age-related dystrophic
calcification revealed the presence of membranous
material around cell debris, which was assumed to be
composed of phospholipids interacting with PGs (Kim
and Huang, 1971; Kim, 1976) and is someway
reminiscent of PPLs.
Moreover, some functional analogy was assumed to
exist (Ortolani et al., 2002a,b, 2003) between PPL-
forming lipidic material and the so called "nucleational
core complexes", which were found also to include
glysosaminoglycan-associated proteins interacting with
calcium-acidic-phospholipid-phopsphate complexes and
collagens (Wu et al., 1991; Kirsch et al., 1994),
suggesting a possible association with PGs and their
additional role in promoting calcification.
An unanswered question is what type of upstream
cell death will trigger this unusual type of cell
degeneration. A wide body of evidence exists to show
that calcification is closely related to cell death, with
apoptosis as the major candidate in both physiological
and pathological calcification (Kim, 1995). However, in
vascular pathologies including atherosclerosis, calcific
events have been reported to occur via either apoptosis
(Proudfoot et al., 2000; Proudfoot and Shanahan, 2001;
Jian et al., 2003; Trion and van der Laarse, 2004) or
oncosis (Crisby et al., 1997; Wang et al., 1999).
As stressed above, earlier cell death stages likely
occur during sample pre-implantation treatment, which
is inherent in the calcification model used, because of
the presence of nitrogen atmosphere combined with
glutaraldehyde-induced toxic effects, while subsequent
subdermal implantation will add further critical
conditions to already suffering, dying cells. The active
cell reactions observed in 2-day-implants, such as the
seeming emission and subsequent reabsorption of
lamellipodium-like cytoplasm protrusions, were not
indicative of apoptosis or oncosis, since there were
neither cell body shrinkage, membrane blebbing, or
chromatin margination, nor cell swelling, membrane
disruption, or cellular content release into the
surrounding tissue. However, several alterations, such as
the formation of dense bodies, cytoplasm condensation
and membrane fading instead of disintegration, could
suggest that early apoptosis had started. The absence of
more advanced apoptosis-related steps, and their
replacement by the degeneration steps as described, can
be explained by postulating that apoptosis has been
initiated but not completed, owing to the particular
sequence of the pre-implantation environment and that
existing in rat subcutis.
To highlight the effectiveness of the environment in
conditioning tissue modifications, it is worth adding that
different effects were also observed to depend on valve
leaflet topography. In contrast to the degenerating
features exhibited by co-resident, interstitial cells, at the
surface of implants up to two weeks, the endothelial
cells appeared well preserved, showing features
comparable to those in control samples (observation
omitted in Result session). This apparently conflicting
result can be explained by assuming that, in spite of its
low concentration, 0.6% GA can act as an effective
fixation agent when interacting with samples directly
and promptly. Conversely, a delay in GA entering valve
stroma and reaching interstitial cells will enable them to
prime early defence mechanisms against increasing
hypoxic conditions before they undergo death. This
assumption could also explain why more prominent
calcification occurs in spongiosa than in fibrosa and
ventricularis layers, as observed in the present work in
agreement with previous reports (Ferrans et al., 1980;
Levy et al., 1983; Schoen et al., 1985; Ortolani et al.,
2002a).
Work is in progress to gain further insights into the
nature of this type of cell death, the mechanisms
involved, and any possible concurrent expression of
calcification-associated proteins, as reported (Levy et al.,
1980, 1983, 1991; Maranto and Schoen, 1988; Shen et
al., 1997; Srivatsa et al., 1997) and suggested by
positivity of PPL-associated material to GA-CB-S
reactions in the present work and previously (Ortolani et
al., 2003).
This study is also going to be extended to human
aortic valves affected by calcific stenosis with the aim of
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assessing whether the subdermal model is only a
convenient procedure to evaluate the calcific propensity
of tissues within short times, thanks to its capacity in
promoting accelerated mineralization, or actually
represents a reliable model for the study in greater detail
of the eziopathogenesis and progression steps in
pathological calcification.
At present, the results obtained enable better
comparison of physiological, pathological and
experimental calcification, when applying the same
procedures used in this investigation to each of these
mineralization processes.
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